Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19

NCT04594343 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Disulfiram
DRUG: Placebo

Sponsor

ETICA

Collaborators

[object Object]